A new review of data for Roche's flu drug Tamiflu has concluded the drug does not reduce hospitalisations and serious complications of the virus – and that it leads to harmful effects in patients.

and most people take 75 mg twice a day for five days, he adds. You’re most likely to benefit from Tamiflu if you have risk factors that predispose you to serious influenza infection. That ...

Oseltamivir (as phospate ... unavailable; have RPh compound an emergency supply of oral susp. from 75mg caps (see full labeling for preparation). ≥13yrs: Treatment: 75mg twice daily for 5 ...

There isn’t a widespread shortage of Oseltamivir, commonly known by its brand name Tamiflu. But you still might have issues finding it. In February, the U.S. Centers for Disease Control and ...

Methods: Adolescents and adults (13-97 years, n = 4015) presenting within 36 hours of onset of influenza symptoms were randomised to receive oseltamivir 75mg or placebo twice daily for 5 days ...

Older adults had a lower risk of dying from the flu when they took oseltamivir (Tamiflu) during influenza hospitalizations, regardless of whether or not they were vaccinated against the virus ...

Sanofi has made a bold play to bolster its consumer health business, licensing non-prescription rights to Roche’s influenza drug Tamiflu – even though there’s no guarantee it will be ...

The purpose of the present pooled analysis was to bring together data from ten clinical trials examining the effects of oseltamivir in shortening the duration and alleviation of symptoms of ...